This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Debard, N. Articles by Bout, D. Search for Related Content PubMed PubMed Citation Articles by Debard, N. Articles by Bout, D.

 Previous Article  |  Next Article 

Infect. Immun., 06 1996, 2158-2166, Vol 64, No. 6
Copyright © 1996, American Society for Microbiology

Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection

N Debard, D Buzoni-Gatel and D Bout
Laboratoire d'Immunologie des Maladies Infectieuses, Faculte des Sciences Pharmaceutiques, Tours, France.

SAG1 protein of Toxoplasma gondii was evaluated as a protective antigen in mucosal immunization with cholera toxin as an adjuvant. CBA/J mice intranasally immunized with a combination of SAG1 and cholera toxin exhibited significantly fewer cysts in the brain after oral infection with the 76K strain of T. gondii than control mice. This acquired protection lasted at least 5 months. Protected mice developed high levels of serum anti-SAG1 immunoglobulin G antibodies as well as an enhanced systemic cellular response, as assessed by the proliferation of splenocytes in response to SAG1 restimulation in vitro. This cellular proliferation was associated with an increase of interleukin-2 and interleukin-5 synthesis and with barely detectable gamma interferon production. Splenic immune T cells were shown to convey modest protection to recipients against development of brain cysts following oral infection with T. gondii. Significant production of anti-SAG1 immunoglobulin A was induced in intestinal secretions of protected mice. These results indicate that intranasal immunization with SAG1 and cholera toxin can induce mucosal and systemic immune responses and affords partial and long-lasting resistance against the establishment of chronic toxoplasmosis.

This article has been cited by other articles:

• Cerede, O., Dubremetz, J. F., Soete, M., Deslee, D., Vial, H., Bout, D., Lebrun, M. (2005). Synergistic role of micronemal proteins in Toxoplasma gondii virulence. JEM 201: 453-463 [Abstract] [Full Text]  
• Rachinel, N., Buzoni-Gatel, D., Dutta, C., Mennechet, F. J. D., Luangsay, S., Minns, L. A., Grigg, M. E., Tomavo, S., Boothroyd, J. C., Kasper, L. H. (2004). The Induction of Acute Ileitis by a Single Microbial Antigen of Toxoplasma gondii. J. Immunol. 173: 2725-2735 [Abstract] [Full Text]  
• Martin, V., Supanitsky, A., Echeverria, P. C., Litwin, S., Tanos, T., De Roodt, A. R., Guarnera, E. A., Angel, S. O. (2004). Recombinant GRA4 or ROP2 Protein Combined with Alum or the gra4 Gene Provides Partial Protection in Chronic Murine Models of Toxoplasmosis. CVI 11: 704-710 [Abstract] [Full Text]  
• Ismael, A. B., Sekkai, D., Collin, C., Bout, D., Mevelec, M.-N. (2003). The MIC3 Gene of Toxoplasma gondii Is a Novel Potent Vaccine Candidate against Toxoplasmosis. Infect. Immun. 71: 6222-6228 [Abstract] [Full Text]  
• Balmelli, C., Demotz, S., Acha-Orbea, H., De Grandi, P., Nardelli-Haefliger, D. (2002). Trachea, Lung, and Tracheobronchial Lymph Nodes Are the Major Sites Where Antigen-Presenting Cells Are Detected after Nasal Vaccination of Mice with Human Papillomavirus Type 16 Virus-Like Particles. J. Virol. 76: 12596-12602 [Abstract] [Full Text]  
• Bonenfant, C., Dimier-Poisson, I., Velge-Roussel, F., Buzoni-Gatel, D., Del Giudice, G., Rappuoli, R., Bout, D. (2001). Intranasal Immunization with SAG1 and Nontoxic Mutant Heat-Labile Enterotoxins Protects Mice against Toxoplasma gondii. Infect. Immun. 69: 1605-1612 [Abstract] [Full Text]  
• Haumont, M., Delhaye, L., Garcia, L., Jurado, M., Mazzu, P., Daminet, V., Verlant, V., Bollen, A., Biemans, R., Jacquet, A. (2000). Protective Immunity against Congenital Toxoplasmosis with Recombinant SAG1 Protein in a Guinea Pig Model. Infect. Immun. 68: 4948-4953 [Abstract] [Full Text]  
• Velge-Roussel, F., Marcelo, P., Lepage, A. C., Buzoni-Gatel, D., Bout, D. T. (2000). Intranasal Immunization with Toxoplasma gondii SAG1 Induces Protective Cells into Both NALT and GALT Compartments. Infect. Immun. 68: 969-972 [Abstract] [Full Text]  
• Dupuy, C., Buzoni-Gatel, D., Touze, A., Bout, D., Coursaget, P. (1999). Nasal Immunization of Mice with Human Papillomavirus Type 16 (HPV-16) Virus-Like Particles or with the HPV-16 L1 Gene Elicits Specific Cytotoxic T Lymphocytes in Vaginal Draining Lymph Nodes. J. Virol. 73: 9063-9071 [Abstract] [Full Text]  
• Bourguin, I., Moser, M., Buzoni-Gatel, D., Tielemans, F., Bout, D., Urbain, J., Leo, O. (1998). Murine Dendritic Cells Pulsed In Vitro with Toxoplasma gondii Antigens Induce Protective Immunity In Vivo. Infect. Immun. 66: 4867-4874 [Abstract] [Full Text]  
• Letscher-Bru, V., Villard, O., Risse, B., Zauke, M., Klein, J.-P., Kien, T. T. (1998). Protective Effect of Vaccination with a Combination of Recombinant Surface Antigen 1 and Interleukin-12 against Toxoplasmosis in Mice. Infect. Immun. 66: 4503-4506 [Abstract] [Full Text]  
• Giuliani, M. M., Del Giudice, G., Giannelli, V., Dougan, G., Douce, G., Rappuoli, R., Pizza, M. (1998). Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity. JEM 187: 1123-1132 [Abstract] [Full Text]  
• Wortham, C., Grinberg, L., Kaslow, D. C., Briles, D. E., McDaniel, L. S., Lees, A., Flora, M., Snapper, C. M., Mond, J. J. (1998). Enhanced Protective Antibody Responses to PspA after Intranasal or Subcutaneous Injections of PspA Genetically Fused to Granulocyte-Macrophage Colony-Stimulating Factor or Interleukin-2. Infect. Immun. 66: 1513-1520 [Abstract] [Full Text]